StockNews.AISignal intelligence
Helen of Troy Limited · NASDAQ · Consumer Defensive
Browse public HELE signals with their source context and measured market impact. Open any signal for its permanent analysis page.
HELE reported weaker profitability despite revenue exceeding expectations. Q3 adjusted EPS of $1.71 met analyst consensus. Fiscal 2026 EPS outlook lowered to $3.25-$3.75 from $3.75-$4.25. Shares dropped 5.5% to $19.44 following the earnings announcement. Analysts adjusted price targets down to $22 from previous estimates.
View signal analysisHELE's Q3 earnings expected at $1.68 per share, down from $2.67. Quarterly revenue estimated at $502.17 million, a decline from $530.71 million. Shares of HELE fell 3.1% to close at $21.08 recently. Canaccord Genuity rates HELE as Hold with a target of $23. UBS downgraded HELE's price target from $27 to $25, maintaining a Neutral rating.
View signal analysisHELE's Q2 adjusted EPS dropped 51% year-over-year to 59 cents. Quarterly sales fell 8.9% Y/Y to $431.8 million, beating expectations. Forecasts for Q3 EPS are lower than analysts' estimates. FY2026 EPS estimate is below consensus, reflecting ongoing cost pressures. Analysts lowered their price targets for HELE post-earnings announcement.
View signal analysisHELE is set to report Q2 earnings on October 9. Expected earnings per share is 52 cents, down from $1.21 last year. Projected quarterly revenue is $416.77 million, declining from $474.22 million. Recent analysts downgraded HELE's price targets significantly. CEO G. Scott Uzzell was appointed in August 2023.
View signal analysisHelen of Troy missed Q1 profit and sales estimates by large margins. Sales fell 11% year-over-year, driven by Beauty & Wellness product declines. Company forecasts Q2 revenue decline but did not provide full-year guidance. Tariffs and market uncertainty heavily impacted financial results and outlook. HELE shares dropped 25%, reaching the lowest level in over a decade.
View signal analysisHelen of Troy's Q3 2025 sales fell 3% year-over-year. Net income came in below forecasts at $49.6 million. Guidance for full-year EPS was lowered to $4.60-$5.02. The Beauty & Wellness segment saw a 9% decrease in sales. Shares of HELE dropped 4% following the earnings report.
View signal analysis